News & Updates

A daily 100 mg dose of aspirin for 7 years did not reduce the risk of dementia in individuals with diabetes and no history of cardiovascular disease (CVD), according to results of the ASCEND* study presented at AHA 2021.

Individuals who make eating before bedtime a habit risk developing hypertension, a study reports.

The combination of carbocisteine, gingko leaf extract, and milrinone yields significant clinical improvement in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), a recent study has found. In turn, this treatment regimen also leads to better patient quality of life.

The use of inferior vena cava filters appears to effectively reduce the risk of pulmonary embolism (PE) and PE-related and all-cause deaths in patients with venous thromboembolism (VTE), reports a recent meta-analysis.

Pre-eclampsia/eclampsia is associated with a higher risk of hospitalization due to heart failure with preserved ejection fraction (HFpEF), reveals a recent study.

Empagliflozin provides a significant clinical benefit within 90 days and shows no safety concerns in patients hospitalized for acute heart failure (HF), according to results of the EMPULSE trial reported at the American Heart Association (AHA) Scientific Sessions 2021.